Open AccessCD4 Count and anti Retroviral Therapy for HIV Positive Patients with Cancer in Nigeria -A Pilot Study
Author(s) -
Atara Ntekim,
Ayo M. Folasire
Publication year - 2010
Publication title -
clinical medicine insights oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 26
ISSN - 1179-5549
DOI - 10.4137/cmo.s5028
Subject(s) - medicine , malignancy , cancer , human immunodeficiency virus (hiv) , disease , oncology , immunology
Highly Active Anti Retroviral Treatment (HAART) improves the outcome of HIV positive patients treated for cancer. In our center HAART is only commenced in HIV positive patients with malignancy if the CD4 T lymphocyte count is less than 200 cells/ul. Presently, the outcome of treatment in these patients is poor.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom